Skip to content

Herbal treatment for painful menstrual cycle

Therapeutic evaluation of topical Roghan-e-Suddab (Ruta graveolens Linn) in Usr al-Tamth (Primary dysmenorrhea): A double blind placebo-controlled randomized clinical trial. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/102685
Enrollment
44
Registered
2026-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: Roghan e suddab: Patient is advised to apply the oil formulation gently on lower abdominal twice a day for 3 days from the onset of menstruation follow up on C0 C1 C2 And post treatment

Sponsors

Luqman Unani Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients in the age group of 18 to 35 years Regular painful menstrual cycles Associated symptoms like nausea vomiting low backache and VAS score greater than 4

Exclusion criteria

Exclusion criteria: Patients having irregular menstrual cycle Secondary dysmenorrhea Systemic illness Individuals taking oral contraceptives

Design outcomes

Primary

MeasureTime frame
Changes in pain severity, assessed using a 10 cm visual analogue scale VASTimepoint: Changes in pain severity, assessed using a 10 cm visual analogue scale VAS

Secondary

MeasureTime frame
The health related quality of life HRQoL will be evaluated using the Short form Health Survey 12 SF 12 questionnaire at baseline & after completion of the studyTimepoint: Baseline C0 First cycle C1Second cycle C2 & one additional cycle for posttreatment follow up C3

Countries

India

Contacts

Public ContactDr Nikhat Kausar Inamdar

Luqman Unani Medical College Hospital and Research Centre

drjuveriya10@gmail.com7406810517

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026